Vonoprazan Fumarate is the fumarate salt form of vonoprazan, a pyrrole derivative and reversible potassium-competitive acid blocker (P-CAB). It inhibits gastric acid secretion by competitively binding to the potassium ion binding site of the gastric H+/K+ ATPase proton pump.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2098974-13-9
Vonoprazan
pharmaceutical raw material
Vonoprazan fumarate
pharmaceutical raw material
TAK 438
pharmaceutical raw material
5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanol
pharmaceutical intermediate
5-(2-Fluorophenyl)-N,N-dimethyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine
Pharmaceutical intermediate / research reagent
Tegoprazan
pharmaceutical raw material
Revaprazan hydrochloride
pharmaceutical raw material
Fexuprazan
pharmaceutical raw material
(E)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine
ROGSHYHKHPCCJW-WLHGVMLRSA-N
CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=C/C(=O)O)\C(=O)O